Picture of Genus logo

GNS — Genus Share Price

0.000.00%
gb flag iconLast trade - 00:00
HealthcareBalancedMid CapSucker Stock

Momentum

Relative Strength (%)
1m+5.27%
3m-15.47%
6m-50.31%
1yr-46.12%
Volume Change (%)
10d/3m+12.09%
Price vs... (%)
52w High-57.46%
50d MA-1.14%
200d MA-38.47%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)28.81
PEG Ratio (f)3.71
EPS Growth (f)8.42%
Dividend Yield (f)1.3%
Valuation (ttm)IndustryMarket
Price to Book Value3.47
Price to Tang. Book5.02
Price to Free Cashflown/a
Price to Sales3.1
EV to EBITDA26.77

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital4.78%
Return on Equity7.07%
Operating Margin6.34%

Financial Summary

Year End 30th JunUnit201720182019202020212022E2023ECAGR / Avg
Total Revenue£m459.1470.3488.5551.4574.3572.58605.638.14%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+7.95-9.8-3.06+25.19+51.1-12.09+11.29n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Latest News & Insights for GNS

Which way now for the Genus share price? background image

Which way now for the Genus share price?

Geopolitical and economic turmoil has changed the outlook for companies across all industry sectors. For investors who own shares in them, the question now is whether these stocks are worth holding and where their prices will go from h...

Is there momentum behind the Genus share price? background image

Is there momentum behind the Genus share price?

It has been a wild ride for some of the UK's biggest quoted companies over the past year. Economic uncertainty persists and the question on the minds of many investors is where the prices of stocks like Genus (LON:GNS) will go from her...

How has the Genus share price performed over the past year? background image

How has the Genus share price performed over the past year?

With areas of the economy continuing to recover from the impact of Covid, stock market investors have been laser-focused on the share prices of some of the UK’s biggest companies - including Genus (LON:GNS). Genus is one of just 200 UK...

What analysts are saying about shares in Genus background image

What analysts are saying about shares in Genus

Analysts have been under intense pressure in recent months as they try to make sense of the impact of Covid-19 on companies like Genus (LON:GNS). As one of just 200 shares in the UK market valued at more than £1.0 billion (its market c...

Is there momentum behind the Genus share price? background image

Is there momentum behind the Genus share price?

It has been a wild ride for some of the UK's biggest quoted companies over the past year. Economic uncertainty persists and the question on the minds of many investors is where the prices of stocks like Genus (LON:GNS) will go from her...

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Jun 202230th Jun 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Genus EPS forecast chart

Profile Summary

Genus PLC is a United Kingdom-based animal genetics company. The Company provides farmers with genetics that enable them to produce animal protein for breeding pigs and cattle, in the form of meat and milk. The Company’s operating segments includes Genus PIC, Genus ABS and Research and Development. The Genus PIC segment is engaged in porcine sales business. The Genus ABS segment is engaged in bovine sales business. The Company's development activities include developing and maintaining its porcine genetic nucleus herd and bovine pre-stud herds. The Company operates approximately around 25 countries on six continents, with research laboratories located in Madison, Wisconsin, United States.

Directors

Last Annual
June 30th, 2021
Last Interim
December 31st, 2021
Incorporated
September 26th, 1994
Public Since
July 6th, 2000
No. of Employees
3,096
Sector
Biotechnology & Medical Research
Industry
Healthcare
Exchange
gb flag iconLondon Stock Exchange
Shares in Issue
65,770,066

GNS Share Price Performance

Latest News for GNS

Upcoming Events for GNS

Full Year 2022 Genus PLC Earnings Release

Similar to GNS

Picture of 4Basebio logo

4Basebio

gb flag iconLondon Stock Exchange

Picture of 4d Pharma logo

4d Pharma

gb flag iconLondon Stock Exchange

Picture of Allergy Therapeutics logo

Allergy Therapeutics

gb flag iconLondon Stock Exchange

Picture of Arecor Therapeutics logo

Arecor Therapeutics

gb flag iconLondon Stock Exchange

Picture of Avacta logo

Avacta

gb flag iconLondon Stock Exchange

FAQ

Or unlock with your email

Or unlock with your email